1. All
  2. Press Releases
  3. Events
  4. Publications

Primo Biotechnology and Terthera B.V. Announce Strategic Partnership to Advance Terbium-161 Radioligand Therapies in Taiwan

Press Releases
普瑞默生技完成A輪募資 目標2026啟動IPO布局全球放射藥物市場

Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy

Press Releases

Primo’s Taoyuan Facility Achieves PIC/S GMP Certification, Paving the Way for Global Expansion in Nuclear Medicine.

Press Releases

Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market

Press Releases

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Press Releases

Primo Biotechnology Partners with Antelope Surgical Solutions for World’s First FDA-Approved Phase I/II Trial of AS1986NS

Press Releases

An updated radiosynthesis of [18F]PSMA-1007 by a Neptis RS synthesizer with fully EP compliant quality control test at the medical center in Northern Taiwan.

Publications

Clinical Impact of Radium-223 on Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis

Publications

The radiosynthesis of [18F]fluoroacetate by a Tracerlab MX synthesizer in Shin-Kong Memorial Hospital.

Publications

Does 18F-PSMA-1007 PET/CT Effectively Detect Among Patients with Suspected Prostate Cancer-Case Report

Publications

The evaluation in the efficacy of Radium-223 for overall survival among patients with mCRPC: A meta-analysis

Publications

Application of Radelumin(PSMA-1007) combined with MRS(Magnetic resonance spectroscopy) in assessment of benign and malignant prostate cancer.

Publications